# Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy

> **NCT01189448** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 149 (actual)

## Conditions studied

- Congenital Toxoplasmosis

## Interventions

- **DRUG:** Pyrimethamine/Sulfadiazine
- **DRUG:** Spiramycine

## Key facts

- **NCT ID:** NCT01189448
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-07
- **Final completion:** 2016-04
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01189448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01189448, "Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01189448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*